Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring

计划入组 125 人 · 首次发布于 2025 年 7 月 11 日

TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function

计划入组 450 人 · 首次发布于 2026 年 9 月 17 日

Donor-derived Cell-free DNA in Kidney Transplant Recipients

计划入组 143 人 · 首次发布于 2024 年 6 月 26 日

cell-free stem cell-derived extract formulation

Autologous and Donor-derived CD7 CAR-T Therapy(Beijing GoBroad Hospital)

Cell-free Stem cell-derived Extract(General Therapeutics)

Generation Bio

United States

KRKA dd

Slovenia

NATIONAL MARROW DONOR PROGRAM

United States

Oncocyte's Blood-Based Transplant Rejection Assay Shows Long-Term Clinical Validity in 13-Year Study

Donor-Derived Cell-Free DNA Emerges as Leading Biomarker in Kidney Transplant Rejection Surveillance, Market to Reach $3.98 Billion by 2036

PEDAL Study Demonstrates Prospera Kidney Test Accurately Predicts Long-Term Outcomes After Transplant Rejection